P&G Looks Expensive

We like what we're seeing from the wide-moat firm but think it's overvalued.

Securities In This Article
Procter & Gamble Co
(PG)

The sustained acceleration in wide-moat Procter & Gamble’s PG top line throughout fiscal 2019 is a testament to the merits of its strategic agenda to rightsize its brand mix and drive productivity savings to fuel further investments behind consumer-valued innovation. The fruits of these efforts were again evident in its outsize organic sales growth (a whopping 7% in the fourth quarter, above the 4%-5% in each of the previous three quarters) that reflected a balanced contribution from higher prices, increased volumes, and favorable mix, each amounting to a 2%-3% benefit to sales in the quarter.

However, we don’t think the firm is aiming to reignite its sales trajectory at any cost; rather, we believe management is squarely focused on generating profitable growth longer term. As a part of these efforts, P&G aims to extract another $10 billion in costs, with an eye toward reducing overhead, lowering material costs, and increasing manufacturing and marketing productivity. In the quarter, this initiative contributed to a 120-basis-point improvement in underlying gross margins to 48.8%, although these efficiencies were partially offset by higher input costs, unfavorable mix, and unfavorable foreign exchange.

While we will likely bump up our $98 fair value estimate by a low- to mid-single-digit percentage to reflect the firm’s full-year performance and the time value of money, we view the shares as frothy at current levels (especially after the mid-single-digit advance following results), trading at a 15%-20% premium to our valuation. Despite the prudence of its course, we think the combination of much tougher comparisons (relative to the muted top-line increases it was lapping this year, including just a 1% bump in the year-ago fourth quarter) and persistent competitive headwinds (including the potential for increased promotional activity) may knock some of the shine off of P&G’s momentum.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

More in Stocks

About the Author

Erin Lash, CFA

Sector Director
More from Author

Erin Lash, CFA, is a sector director, AM Consumer, for Morningstar*. In addition to leading the sector team, she covers packaged food and household and personal care companies. Beyond managing a team of nine analysts and associates covering an array of consumer firms, Lash also conducts fundamental analysis of 13 multi-billion-dollar market capitalization firms in the packaged food and household and personal care space.

Before joining Morningstar in 2006, Lash spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance. In this capacity, Lash analyzed financial statements, business strategy, and fundamentals of owned companies and potential investments, presenting her recommendations based on this analysis to State Farm portfolio managers for ownership consideration.

Lash holds a bachelor’s degree in finance from Bradley University’s Foster College of Business. She also holds a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. Lash has completed the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc

Sponsor Center